Skip to main content

Seqirus Leadership Team

 The Seqirus Leadership Team has deep expertise in the business of influenza and a shared commitment to public health.

Stephen Marlow

Stephen Marlow

General Manager

Kian Meng Lim

Ken Lim

Senior Vice President, Strategy & Finance

Russell Basser, Seqirus

Russell Basser

Senior Vice President, Research & Development

Chris Larkins

Chris Larkins

Senior Vice President, Global Operations

Lorna Meldrum

Lorna Meldrum

Vice President, Commercial Operations, International Markets & Pandemic

David Ross

Dave Ross

Vice President Commercial Operations, North America

Gyuri Endes_Revised May 2019_768x430

Gyuri Endes

Vice President, Human Resources

Seqirus Vice President, mRNA Program Lead Roberta Duncan

Roberta Duncan

Vice President, mRNA Program Lead

Gregg Sylvester

Gregg Sylvester

Chief Medical Officer

Sharon McHale

Sharon McHale

Head of Global Policy & Government Affairs

Karen Netherton, Vice President, Quality

Karen Netherton

Vice President, Quality

Canadian Leadership

Bertrand Roy

Bertrand Roy, Ph.D.

Country Head, Medical Affairs, Canada

Gillian Stafford

Gill Stafford

Commercial Operations Director, Canada

Our Values

Seqirus shares the CSL Group Values which have guided the company for many decades. Our Values are fundamental to our success — helping us to save lives, protect the health of people, and earn our reputation as a trusted and reliable global leader. They’re at the core of how our employees interact with others, make decisions and solve problems. 
They are:

Patient Focus

Patient Focus

We deliver on our promise to patients.

Research and Innovation from Seqirus


We turn innovative thinking into solutions.



We walk the talk.



We are stronger together.

Superior Performance

Superior Performance

We take pride in our results.